{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "31722-834",
      "generic_name": "Entecavir",
      "labeler_name": "Camber Pharmaceuticals, Inc.",
      "brand_name": "Entecavir",
      "active_ingredients": [
        {
          "name": "ENTECAVIR ANHYDROUS",
          "strength": "1 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "31722-834-30",
          "description": "30 TABLET in 1 BOTTLE (31722-834-30)",
          "marketing_start_date": "20150821",
          "sample": false
        },
        {
          "package_ndc": "31722-834-31",
          "description": "10 TABLET in 1 BLISTER PACK (31722-834-31)",
          "marketing_start_date": "20150821",
          "sample": false
        },
        {
          "package_ndc": "31722-834-32",
          "description": "100 TABLET in 1 CARTON (31722-834-32)",
          "marketing_start_date": "20150821",
          "sample": false
        },
        {
          "package_ndc": "31722-834-90",
          "description": "90 TABLET in 1 BOTTLE (31722-834-90)",
          "marketing_start_date": "20150821",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Camber Pharmaceuticals, Inc."
        ],
        "rxcui": [
          "485434",
          "485436"
        ],
        "spl_set_id": [
          "01ec50a1-6c6c-46f0-8c74-73542b0a59c3"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175656",
          "N0000175459",
          "N0000009947"
        ],
        "pharm_class_epc": [
          "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
        ],
        "unii": [
          "NNU2O4609D"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "2b442999-71b5-88f6-e063-6394a90a9d6e",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20150821",
      "product_id": "31722-834_2b442999-71b5-88f6-e063-6394a90a9d6e",
      "application_number": "ANDA205740",
      "brand_name_base": "Entecavir",
      "pharm_class": [
        "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Nucleoside Analog [EXT]",
        "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
      ]
    }
  ]
}